Emany Sravan Kumar purchased ~$300K in Ironwood Pharmaceuticals, Inc. stock
Ironwood Pharmaceuticals, Inc. (IRWD) · SVP, Chief Financial Officer · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
90-day return
+37.3%vs SPY +6.5%
Trade Details · Public SEC Filing
Insider
Emany Sravan Kumar
Role
SVP, Chief Financial Officer
Transaction
Open-Market Purchase
Approx. Value
~$300K
Trade Date
Sep 15, 2023
Company
Ironwood Pharmaceuticals, Inc.
Ticker
IRWDSource
SEC EDGAR Form 4
Why This Trade Stands Out
Strong conviction signal
Scored above average across multiple factors. Roughly 15% of insider trades qualify as Strong.
~$300K purchase
A meaningful investment of personal capital. The average insider purchase is around $150K, putting this in the typical range for serious positions.
SVP, Chief Financial Officer
CFOs have direct access to financials before they become public. Their trades are among the most closely watched by institutional investors.
+37.3% in 90 days (S&P 500: +6.5%)
This trade beat the S&P 500 by 30.8 percentage points over 90 days. We track performance on every insider trade so you can see who consistently outperforms.
How good is Emany Sravan Kumar at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
On September 15, 2023, Emany Sravan Kumar — SVP, Chief Financial Officer of Ironwood Pharmaceuticals, Inc. — filed a Form 4 with the SEC disclosing an open-market purchase of approximately ~$300K in Ironwood Pharmaceuticals, Inc. (IRWD) stock.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
In the 90 days following this trade, IRWD returned +37.3% versus +6.5% for the S&P 500 over the same period.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time Emany Sravan Kumar trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
More IRWD Insider Activity
MCCOURT Thomas A
Feb 23, 2026
~$1.3M
STRONG
MCCOURT Thomas A
Feb 10, 2025
~$428K
STRONG
MCCOURT Thomas A
Feb 12, 2024
~$4.3M
STRONG
MCCOURT Thomas A
Feb 27, 2023
~$1.5M
STRONG
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free